Drawing for GOPREVY

USPTO serial 79282294

GOPREVY

Reviewed by CopyMark Law Group

Reg. 6138839Status 700Renewal
Filing date
Status date
Registration date
Sep 1, 2020
Examiner
LAVACHE, LINDA M
Law office
PETITIONS OFFICE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GOPREVY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher Hanes

Christopher Hanes GSK5 MOORE DRIVELBP, 5.5ARESEARCH TRIANGLE PARK, NC 27709-3398

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; all of the foregoing expressly excluding vaccines, pharmaceutical preparations for the prevention and/or treatment of infectious diseases and disorders, and pharmaceutical preparations for the prevention and/or treatment of pneumococcal disease and/or pneumoniaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 28, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 9, 2021LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 13, 2020GPNXNOTIFICATION PROCESSED BY IB—
Nov 1, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 28, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 28, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 1, 2020GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Sep 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 22, 2020CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jun 17, 2020APETASSIGNED TO PETITION STAFF—
Jun 16, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 19, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2020DOCKASSIGNED TO EXAMINER—
Apr 11, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 7, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 2, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance